<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02510105</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0236</org_study_id>
    <nct_id>NCT02510105</nct_id>
  </id_info>
  <brief_title>Tomodensitometric Study of Pulmonary Effects of Intrapulmonary Percussive Ventilation in ARDS Patients</brief_title>
  <acronym>PERVE-ARDS</acronym>
  <official_title>Tomodensitometric Study of Pulmonary Effects of Intrapulmonary Percussive Ventilation in ARDS Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Estaing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      The study is intended to elucidate the pulmonary effects of Intrapulmonary Percussive
      Ventilation (IPV) with VDR4 ventilator of patients with ARDS, using computed tomography (CT).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective clinical study in ICU of ventilated patients with ARDS. The morphologic pulmonary
      effects of IPV with VDR4 are not known to the investigators' knowledge.

      The main aim is to quantify recruited, normally aerated and overinflated parts of the lungs
      after a 1 hour treatment with IPV.

      Patients with ARDS (focal and non focal) consecutively admitted to the investigators' ICU are
      enrolled after informed consent.

      Patients are intubated and ventilated with Servo-I (GE) and ventilation is optimized
      according to ARDS-network recommandations.

      A first thoracic CT-scan is performed with ICU ventilator and then the patient is ventilated
      with VDR4 during 1 hour.

      A second thoracic CT-scan is then performed and the patient re-ventilated with ICU
      ventilator.

      Arterial blood gases and hemodynamic parameters are recorded during experiments.

      CT-scan are analysed and compared for normally aerated, overinflated and recruited lung
      parenchyma. Regions are determined thanks to their Hounsfield units (HU).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline (H0) in volume of overinflated lung at H1</measure>
    <time_frame>at Hour 0(just before Intrapulmonary Percussive Ventilation) and Hour 1(just after Intrapulmonary Percussive Ventilation)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of normally aerated lung</measure>
    <time_frame>at Hour 0 (just before Intrapulmonary Percussive Ventilation ) and Hour 1 (just after Intrapulmonary Percussive Ventilation)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume of recruited lung</measure>
    <time_frame>at day 1 (between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>at day 1 ((every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>at day 1 (every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Arterial blood gaz</measure>
    <time_frame>at day 1 ((every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evolution of catecholamine doses (Âµg/Kg/min)</measure>
    <time_frame>at day 1 (every 10 min between H0 and H1)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>ARDS patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VDR4 ventilator (Intrapulmonary Percussive Ventilation)</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CT scan</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Servo-i</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>- Intubation</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ventilation ( with an ICU conventional ventilator)</intervention_name>
    <arm_group_label>ARDS patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients ventilated more than 48 h

          -  Sedated patients

          -  ARDS moderate or severe (Berlin 2012)

          -  Patients who have given their consent or his family

          -  Patients aged between 18 and 85 years

        Exclusion Criteria:

          -  Pregnant ou lactating women

          -  Hemodynamic instability

          -  Chronic respiratory insufficiency.

          -  Pneumothorax

          -  Fistulae bronchopleural
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel CONSTANTIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Michel CONSTANTIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>July 27, 2015</last_update_submitted>
  <last_update_submitted_qc>July 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critical Care</keyword>
  <keyword>ARDS</keyword>
  <keyword>Intrapulmonary Percussive Ventilation</keyword>
  <keyword>VDR4</keyword>
  <keyword>Lung aeration</keyword>
  <keyword>CT scan</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

